Aims and Scope

Aims and Scope

The Rheumatology Quarterly is a peer-reviewed periodical journal that publishes quarterly (March, June, September, December) in English electronically. The journal publishes original contributions in the form of experimental and clinical research articles, case reports and litrerature review, reviews, news, letters to the editor and authors, as well as announcements related to all topics of rheumatology.

The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.

Title: The Rheumatology Quarterly

Journal abbreviation: Rheumatol Q

E-ISSN: 2980-1559

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Author(s) and the copyright owner(s) grant access to all users for the articles published in the Rheumatology Quarterly free of charge. Articles may be used provided that they are cited.

Open Access Policy is based on the rules of Budapest Open Access Initiative (BOAI). By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited.

The Rheumatology Quarterly does not demand any subscription fee, publication fee, or similar payment for access to electronic resources.

Creative Commons

This journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits third parties to share and adapt the content for non-commercial purposes by giving the appropriate credit to the original work.

A Creative Commons license is a public copyright license that provides free distribution of copyrighted works or studies. Authors use the CC license to transfer the right to use, share or modify their work to third parties.

Open access is an approach that supports interdisciplinary development and encourages collaboration between different disciplines. Therefore, the Rheumatology Quarterly contributes to the scientific publishing literature by providing more access to its articles and a more transparent review process.

This journal's advertising sales and editorial processes are separated to ensure editorial independence and reduce the effects of financial interests.

Advertisers are responsible for ensuring that their advertisements comply with applicable laws regarding deceptive and/or offensive content and ethical issues.

Material Disclaimer

Statements or opinions stated in articles published in the journal do not reflect the views of the editors, editorial board and/or publisher; The editors, editorial board, and publisher do not accept any responsibility or liability for such materials. All opinions published in the journal belong to the authors.

Contact & Permissions

Editor in Chief:

Sekib Sokolovic, Prof. MD.

Address: Bolnička 25, Sarajevo 71000, Bosnia and Herzegovina
Phone: +387 33 297 000

Galenos Publishing House

Address: Molla Gürani Mahallesi Kaçamak Sokak No: 21 34093 Fındıkzade - İstanbul/Turkey
Phone: +90 (212) 621 99 25
2024 ©️ Galenos Publishing House